Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium.
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Dr. Vivian J. Bea, an expert in breast cancer disparities, has been named section chief of breast surgical oncology at NewYork-Presbyterian Brooklyn Methodist Hospital. She also serves as an assistant professor of surgery at Weill Cornell Medicine.
Four distinguished Weill Cornell Medicine physician-scientists – Drs. Silvia Formenti, Barbara Hempstead, Lisa Newman and Laura Riley – have been selected as Crain’s Notable Women in Healthcare in New York City.
A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Dr. Lisa Newman, an internationally renowned breast surgeon and researcher, has been appointed chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 20.
